These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6619022)
21. [Role of azlocillin in the treatment of Pseudomonas urinary infections]. Canton P Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606 [TBL] [Abstract][Full Text] [Related]
22. Fosfomycin, piperacillin, azlocillin. Correlation between therapeutic response of mice infected with Pseudomonas aeruginosa and in vitro data. Haag R Chemotherapy; 1984; 30(4):227-36. PubMed ID: 6430654 [TBL] [Abstract][Full Text] [Related]
23. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency. Bergan T J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598 [TBL] [Abstract][Full Text] [Related]
24. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa. Gonzalez MA J Antimicrob Chemother; 1983 May; 11 Suppl B():169-74. PubMed ID: 6352600 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin. Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561 [TBL] [Abstract][Full Text] [Related]
26. [On the excretion of azlocillin with bronchial secretion in children (author's transl)]. Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH Arzneimittelforschung; 1979; 29(12a):1952-4. PubMed ID: 543898 [TBL] [Abstract][Full Text] [Related]
31. The use of azlocillin to treat serious infections. Neu HC; Francke EL; Ortiz-Neu C; Prince AS J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023 [TBL] [Abstract][Full Text] [Related]
33. [Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications]. Rosselli P; Marianelli L; Valenza T; Bartolozzi G Pediatr Med Chir; 1989; 11(4):389-91. PubMed ID: 2694104 [TBL] [Abstract][Full Text] [Related]
34. [Clinical pharmacokinetics of azlocillin]. Singlas E; Haegel C Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies. Delgado FA; Stout RL; Whelton A J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose. Naber KG; Adam D J Antimicrob Chemother; 1983 May; 11 Suppl B():115-20. PubMed ID: 6619021 [TBL] [Abstract][Full Text] [Related]
37. Comparative clinical evaluation of azlocillin and gentamicin. Sabbaj J; Torres M; Loza L J Antimicrob Chemother; 1983 May; 11 Suppl B():175-81. PubMed ID: 6619027 [TBL] [Abstract][Full Text] [Related]
38. Intravenous azlocillin kinetics in patients on long-term hemodialysis. Aletta JM; Francke EF; Neu HC Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815 [TBL] [Abstract][Full Text] [Related]
39. A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants. Prinsloo JG; Delport SD; Moncrieff J; Paton AM J Antimicrob Chemother; 1983 Jul; 12 Suppl A():361-4. PubMed ID: 6352645 [TBL] [Abstract][Full Text] [Related]
40. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Bergan T; Thorsteinsson SB; Steingrimsson O Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]